Assistant A.G. Kanter Delivers Remarks at 2023 Georgetown Antitrust Law Symposium insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.
This study provides an overview of the US healthcare payer landscape and the emerging trends impacting this space, resulting in a slew of opportunities for growth in this evolving landscape. The United States is the world's largest healthcare market, spending over 18% of its GDP on healthcare. The US health insurance landscape has seen significant evolution.
The United States is the world's largest healthcare market, spending over 18% of its GDP on healthcare. The US health insurance landscape has seen significant evolution through various legislations, ranging from the 1940 s laws that established the Centers for Medicare and Medicaid Services to the Affordable Care Act of 2010. These changes not only affect.
WASHINGTON, April 30 The American Medical Association, Chicago, Illinois, has issued a public comment to the Federal Trade Commission and the U.S. Department of Justice. To: The Honorable Lina M. Khan, Chair, Federal Trade Commission, Office of the Secretary, Room H-135, 600 Pennsylvania Avenue, NW, Washington, DC 20580. The AMA commends the Department of Justice and the.
Dear Attorney General Garland and Chair Khan:
We write today regarding the recently expanded antitrust authorities of the Department of Justice (DOJ) and Federal Trade Commission (FTC) over the health insurance industry following the enactment of the Competitive Health Insurance Reform Act (CHIRA) of 2020.
The CHIRA protects consumers from anticompetitive practices by repealing the McCarran-Ferguson Act’s outdated antitrust exemption for the health insurance industry. Decades of consolidation by health insurance brokers has primed the industry for abuse, allowing insurers to exert market power in order to raise premiums, restrict competition, and deny consumers choice.
[1] Despite the clearly anticompetitive nature of these practices, before the CHIRA was enacted, regulators lacked the power to stop insurers’ misconduct due to the industry’s antitrust exemption. For example, as recently as last December, a U.S. District Court dismissed antitrust claims against the Blue Cro